methoxyhydroxyphenylglycol has been researched along with serine in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (50.00) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 3 (18.75) | 29.6817 |
2010's | 4 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kato, M; Matsuura, M; Nankai, M; Okubo, Y; Semba, J; Takahashi, R | 1 |
Ogawa, N; Ujike, H; Yamamoto, M | 2 |
Karai, N; Kato, T; Katsube, J; Katsuyama, M; Nakamura, M | 2 |
Gibson, CJ | 1 |
Semba, J; Takahashi, R | 1 |
Kuroda, H; Nukina, I; Ogawa, N; Ota, Z; Yamamoto, M | 1 |
Cilmi, KM; Hoeldtke, RD; Mattis-Graves, K | 1 |
Andree, TH; Gong, X; Liu, F; Marquis, K; Reinhart, P; Zhang, G | 1 |
Choe, ES; Shin, EH; Wang, JQ | 1 |
Aperia, A; Axehult, G; Bondar, A; Brismar, H; Gunnarson, E; Krieger, P; Song, Y; Zelenin, S; Zelenina, M | 1 |
Hoeffer, CA; Klann, E; McBride, SM; Miyawaki, T; Sharma, A; Takayasu, Y; Zukin, RS | 1 |
Birnbaum, SG; Collins, KA; Gibson, JR; Guo, W; Hays, SA; Hu, JH; Huber, KM; Ronesi, JA; Tsai, NP; Worley, PF | 1 |
Bassell, GJ; Gross, C; Muddashetty, RS; Nalavadi, VC | 1 |
Huber, KM; Niere, F; Wilkerson, JR | 1 |
2 trial(s) available for methoxyhydroxyphenylglycol and serine
Article | Year |
---|---|
Neuroendocrinological effects of L-threo-3, 4-dihydroxyphenylserine (DOPS), a putative norepinephrine precursor, on healthy volunteers.
Topics: Adult; Analysis of Variance; Brain; Droxidopa; Growth Hormone; Humans; Hydrocortisone; Kinetics; Male; Methoxyhydroxyphenylglycol; Prolactin; Serine; Thyrotropin | 1990 |
DL-Threo-3,4-dihydroxyphenylserine does not exert a pressor effect in orthostatic hypotension.
Topics: Adult; Aged; Analysis of Variance; Blood Pressure; Chromatography, High Pressure Liquid; Droxidopa; Drug Evaluation; Female; Humans; Hypotension, Orthostatic; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Normetanephrine; Posture; Serine | 1984 |
14 other study(ies) available for methoxyhydroxyphenylglycol and serine
Article | Year |
---|---|
Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.
Topics: Droxidopa; Electromyography; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; MMPI; Movement Disorders; Serine | 1985 |
Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Droxidopa; Drug Therapy, Combination; Glycols; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Parkinson Disease; Serine | 1986 |
Effect of L-threo-3,4-dihydroxyphenylserine(L-threo-DOPS) on brain and serum MHPG levels in mice: evidence for NE formation in CNS.
Topics: Animals; Benserazide; Brain; Brain Chemistry; Dose-Response Relationship, Drug; Droxidopa; Glycols; Male; Methoxyhydroxyphenylglycol; Mice; Norepinephrine; Serine | 1987 |
Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Brain; Catecholamines; Dopamine; Droxidopa; Kinetics; Levodopa; Male; Methoxyhydroxyphenylglycol; Mice; Nialamide; Norepinephrine; Protein Precursors; Rats; Rats, Inbred Strains; Serine; Substrate Specificity | 1987 |
Increase in norepinephrine turnover after tyrosine or DL-threo-3,4-dihydroxyphenylserine (DL-threo-DOPS).
Topics: Animals; Benzylamines; Brain; Droxidopa; Male; Methoxyhydroxyphenylglycol; Mice; Norepinephrine; Serine; Tyrosine | 1988 |
The effects of L-threo-dihydroxyphenylserine on norepinephrine metabolism in rat brain.
Topics: alpha-Methyltyrosine; Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain; Carbidopa; Droxidopa; Fusaric Acid; Male; Methoxyhydroxyphenylglycol; Methyltyrosines; Norepinephrine; Rats; Rats, Inbred Strains; Reserpine; Serine | 1985 |
Improvement in freezing phenomenon of Parkinson's disease after DL-threo-3, 4-dihydroxyphenylserine.
Topics: Aged; Benserazide; Droxidopa; Gait; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Parkinson Disease; Serine | 1984 |
The inhibition of glycogen synthase kinase 3beta by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Abeta peptides.
Topics: Amyloid beta-Peptides; Animals; Benzoates; Cells, Cultured; Chromones; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glycine; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; In Vitro Techniques; Indoles; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Morpholines; Neurons; Oncogene Protein v-akt; Peptide Fragments; Phosphorylation; Pyridines; Rats; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Resorcinols; Serine; Signal Transduction | 2005 |
Regulation of phosphorylation of NMDA receptor NR1 subunits in the rat neostriatum by group I metabotropic glutamate receptors in vivo.
Topics: Animals; Benzopyrans; Blotting, Western; Electrophoresis, Polyacrylamide Gel; Immunohistochemistry; Male; Methoxyhydroxyphenylglycol; Neostriatum; Phosphorylation; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Serine | 2006 |
Identification of a molecular target for glutamate regulation of astrocyte water permeability.
Topics: Animals; Animals, Newborn; Aquaporin 4; Astrocytes; Benzylamines; Calcium; Cell Line, Transformed; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Glutamic Acid; Green Fluorescent Proteins; Hippocampus; In Vitro Techniques; Methoxyhydroxyphenylglycol; N-Methylaspartate; Permeability; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Serine; Sulfonamides; Transfection; Water | 2008 |
Dysregulation of mTOR signaling in fragile X syndrome.
Topics: Adaptor Proteins, Signal Transducing; Animals; CA1 Region, Hippocampal; Carrier Proteins; Cell Cycle Proteins; Cognition Disorders; Disease Models, Animal; Eukaryotic Initiation Factor-4A; Eukaryotic Initiation Factors; Excitatory Postsynaptic Potentials; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gene Expression Regulation; Immunoprecipitation; In Vitro Techniques; Long-Term Synaptic Depression; Methoxyhydroxyphenylglycol; Mice; Mice, Knockout; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Receptors, Metabotropic Glutamate; Serine; Signal Transduction; Sirolimus | 2010 |
Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome.
Topics: Analysis of Variance; Animals; Carrier Proteins; Cycloheximide; Disease Models, Animal; Electric Stimulation; Exploratory Behavior; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gene Expression Regulation; Hippocampus; Homer Scaffolding Proteins; Immunoprecipitation; In Vitro Techniques; Long-Term Potentiation; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Nerve Net; Patch-Clamp Techniques; Peptides; Physics; Protein Synthesis Inhibitors; Rats; Rats, Long-Evans; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Serine; Signal Transduction; TOR Serine-Threonine Kinases | 2012 |
Dephosphorylation-induced ubiquitination and degradation of FMRP in dendrites: a role in immediate early mGluR-stimulated translation.
Topics: Analysis of Variance; Animals; Boronic Acids; Bortezomib; Cells, Cultured; Dendrites; Disks Large Homolog 4 Protein; Drosophila Proteins; Embryo, Mammalian; Enzyme Inhibitors; Female; Fragile X Mental Retardation Protein; Gene Expression Regulation; Green Fluorescent Proteins; Hippocampus; Immunoprecipitation; Intracellular Signaling Peptides and Proteins; Leupeptins; Male; Membrane Proteins; Methoxyhydroxyphenylglycol; Mutation; Neurons; Okadaic Acid; Phosphoprotein Phosphatases; Phosphorylation; Protein Biosynthesis; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; RNA, Messenger; Serine; Signal Transduction; Synapses; Transfection; Ubiquitination | 2012 |
Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression.
Topics: Animals; Animals, Newborn; Cells, Cultured; Cytoskeletal Proteins; Dendrites; Electric Stimulation; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; Fragile X Mental Retardation Protein; Gene Expression Regulation; Green Fluorescent Proteins; Hippocampus; Humans; In Vitro Techniques; Long-Term Synaptic Depression; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; Nerve Tissue Proteins; Neurons; Okadaic Acid; Patch-Clamp Techniques; Phosphorylation; Protein Biosynthesis; Protein Phosphatase 2; Rats; Rats, Long-Evans; Receptors, Metabotropic Glutamate; Serine; Sodium Channel Blockers; Tetrodotoxin; Time Factors; Transfection | 2012 |